Carl Zeiss Meditec AG / Key word(s): Half Year Results 20.04.2015 17:25 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Jena, 20 April 2015: Carl Zeiss Meditec (ISIN: DE0005313704) has achieved revenue of approximately EUR 498 million in the first half of FY 2014/15, based on preliminary data. This corresponds to a growth rate vs. the previous year of approx. 8%. This result was supported by currency effects. On a constant currency basis, growth vs. the previous year amounted to approx. 4%. Earnings before interest & taxes (EBIT) for the first half of FY 2014/15 amounted to approx. EUR 61 million, a decline of 4% vs. the previous year, resulting in an EBIT margin of 12.2% (PY: 13.8%). Adjusted for additional strategic research & development expenses in the area of ophthalmology, as announced in December 2014, EBIT would have reached approx. EUR 68 million, which is 5% above the comparable previous year's value. Earnings per share (EPS) are expected at around EUR 0.37. This corresponds to a decline of 24% vs. the previous year and is mainly related to a negative result from currency hedging. EBIT margin is expected to be within a range of 13-15% in the mid-term. In the current business year, the EBIT margin is also expected to be within this range, if adjusted for the additional strategic research & development expenses in the area of ophthalmology. 20.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: [email protected],[email protected] Internet: www.meditec.zeiss.de ISIN: DE0005313704 WKN: 531370 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------